Owlet, Inc. (OWLT)
5.53
+0.05
(+0.91%)
USD |
NYSE |
May 19, 16:00
5.46
-0.07
(-1.27%)
Pre-Market: 20:00
Owlet Research and Development Expense (Quarterly) : 3.956M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Treace Medical Concepts, Inc. | 4.622M |
| Abbott Laboratories | 767.00M |
| AngioDynamics, Inc. | 7.084M |
| Accuray, Inc. | 8.178M |
| Alphatec Holdings, Inc. | 17.56M |